Recent developments in topoisomerase-targeted cancer chemotherapy

Kirk Hevener, Tatsiana A. Verstak, Katie E. Lutat, Daniel L. Riggsbee, Jeremiah W. Mooney

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The DNA topoisomerase enzymes are essential to cell function and are found ubiquitously in all domains of life. The various topoisomerase enzymes perform a wide range of functions related to the maintenance of DNA topology during DNA replication, and transcription are the targets of a wide range of antimicrobial and cancer chemotherapeutic agents. Natural product-derived agents, such as the camptothecin, anthracycline, and podophyllotoxin drugs, have seen broad use in the treatment of many types of cancer. Selective targeting of the topoisomerase enzymes for cancer treatment continues to be a highly active area of basic and clinical research. The focus of this review will be to summarize the current state of the art with respect to clinically used topoisomerase inhibitors for targeted cancer treatment and to discuss the pharmacology and chemistry of promising new topoisomerase inhibitors in clinical and pre-clinical development.

Original languageEnglish (US)
Pages (from-to)844-861
Number of pages18
JournalActa Pharmaceutica Sinica B
Volume8
Issue number6
DOIs
StatePublished - Oct 1 2018

Fingerprint

Topoisomerase Inhibitors
Drug Therapy
Neoplasms
Enzymes
Podophyllotoxin
Camptothecin
Type I DNA Topoisomerase
Anthracyclines
Biological Products
DNA Replication
Therapeutics
Maintenance
Pharmacology
DNA
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Recent developments in topoisomerase-targeted cancer chemotherapy. / Hevener, Kirk; Verstak, Tatsiana A.; Lutat, Katie E.; Riggsbee, Daniel L.; Mooney, Jeremiah W.

In: Acta Pharmaceutica Sinica B, Vol. 8, No. 6, 01.10.2018, p. 844-861.

Research output: Contribution to journalReview article

Hevener, Kirk ; Verstak, Tatsiana A. ; Lutat, Katie E. ; Riggsbee, Daniel L. ; Mooney, Jeremiah W. / Recent developments in topoisomerase-targeted cancer chemotherapy. In: Acta Pharmaceutica Sinica B. 2018 ; Vol. 8, No. 6. pp. 844-861.
@article{780906383af8440bba3ec4a04bcfaaa5,
title = "Recent developments in topoisomerase-targeted cancer chemotherapy",
abstract = "The DNA topoisomerase enzymes are essential to cell function and are found ubiquitously in all domains of life. The various topoisomerase enzymes perform a wide range of functions related to the maintenance of DNA topology during DNA replication, and transcription are the targets of a wide range of antimicrobial and cancer chemotherapeutic agents. Natural product-derived agents, such as the camptothecin, anthracycline, and podophyllotoxin drugs, have seen broad use in the treatment of many types of cancer. Selective targeting of the topoisomerase enzymes for cancer treatment continues to be a highly active area of basic and clinical research. The focus of this review will be to summarize the current state of the art with respect to clinically used topoisomerase inhibitors for targeted cancer treatment and to discuss the pharmacology and chemistry of promising new topoisomerase inhibitors in clinical and pre-clinical development.",
author = "Kirk Hevener and Verstak, {Tatsiana A.} and Lutat, {Katie E.} and Riggsbee, {Daniel L.} and Mooney, {Jeremiah W.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.apsb.2018.07.008",
language = "English (US)",
volume = "8",
pages = "844--861",
journal = "Acta Pharmaceutica Sinica B",
issn = "2211-3835",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Recent developments in topoisomerase-targeted cancer chemotherapy

AU - Hevener, Kirk

AU - Verstak, Tatsiana A.

AU - Lutat, Katie E.

AU - Riggsbee, Daniel L.

AU - Mooney, Jeremiah W.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The DNA topoisomerase enzymes are essential to cell function and are found ubiquitously in all domains of life. The various topoisomerase enzymes perform a wide range of functions related to the maintenance of DNA topology during DNA replication, and transcription are the targets of a wide range of antimicrobial and cancer chemotherapeutic agents. Natural product-derived agents, such as the camptothecin, anthracycline, and podophyllotoxin drugs, have seen broad use in the treatment of many types of cancer. Selective targeting of the topoisomerase enzymes for cancer treatment continues to be a highly active area of basic and clinical research. The focus of this review will be to summarize the current state of the art with respect to clinically used topoisomerase inhibitors for targeted cancer treatment and to discuss the pharmacology and chemistry of promising new topoisomerase inhibitors in clinical and pre-clinical development.

AB - The DNA topoisomerase enzymes are essential to cell function and are found ubiquitously in all domains of life. The various topoisomerase enzymes perform a wide range of functions related to the maintenance of DNA topology during DNA replication, and transcription are the targets of a wide range of antimicrobial and cancer chemotherapeutic agents. Natural product-derived agents, such as the camptothecin, anthracycline, and podophyllotoxin drugs, have seen broad use in the treatment of many types of cancer. Selective targeting of the topoisomerase enzymes for cancer treatment continues to be a highly active area of basic and clinical research. The focus of this review will be to summarize the current state of the art with respect to clinically used topoisomerase inhibitors for targeted cancer treatment and to discuss the pharmacology and chemistry of promising new topoisomerase inhibitors in clinical and pre-clinical development.

UR - http://www.scopus.com/inward/record.url?scp=85052760597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052760597&partnerID=8YFLogxK

U2 - 10.1016/j.apsb.2018.07.008

DO - 10.1016/j.apsb.2018.07.008

M3 - Review article

VL - 8

SP - 844

EP - 861

JO - Acta Pharmaceutica Sinica B

JF - Acta Pharmaceutica Sinica B

SN - 2211-3835

IS - 6

ER -